ANL (Adlai Nortye Group Ltd.) stock: $15.76, $1.01B market cap, $8.1M cash, $1.03B EV, $862.4M fully diluted market cap. Data from Fully Diluted's biotech stocks database.
Share price
$15.76
Market cap
$1,014.6M
Cash
$8.1M
Enterprise value
$1,032.9M
Balance sheet
Cash
$8.1M
Debt
$26.3M
Net cash
-$18.3M
Enterprise value
$1,032.9M
Basic shares
64.4M shares
Fully diluted shares
54.7M shares
Fully diluted market cap
$862.4M
Cash per share
$0.13
Cash figures as of 2025-12-31. Database snapshot: 2026-09-22.
Price history
Loading ANL daily closes…
Loading price history…
Asset data not yet available for this company.
No lead program on file for this company.
No active ClinicalTrials.gov trials matched to this company as sponsor or collaborator.
Institutional holders
Fund
Shares
Q/Q change
% of portfolio
Filing
ADAR1 Capital Management
1,017,805
+899,896
0.55%
2026-08-14
Braidwell LP
795,214
+795,214
0.34%
2026-08-14
Ikarian Capital
33,899
no change
0.06%
2026-08-14
Institutional holder positions from 13F filings. Q/Q change is vs the prior quarter's filing; % of portfolio is the fund's own reported portfolio weight.
Get the weekly biotech catalyst rundown. Cash runways, financings, and trial readouts for all 714 stocks.